ALEMBICLTD · Real Estate · Real Estate - Development
Composite scorecard: 60/100 — Quality 67 · Valuation 87 · Momentum 0
| Share price | ₹90.27 |
| Market cap | ₹2,310 Cr |
| P/E ratio | 7.3 |
| P/B ratio | 0.9 |
| ROCE | 6.1% |
| Dividend yield | 2.67% |
| Book value | ₹95.06 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹240 Cr | ₹317 Cr | 38.0% |
| 2025 | ₹222 Cr | ₹311 Cr | 42.0% |
| 2024 | ₹157 Cr | ₹269 Cr | 36.0% |
| 2023 | ₹127 Cr | ₹191 Cr | 32.0% |
| 2022 | ₹78 Cr | ₹222 Cr | 18.0% |
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-generation plants and wind power sources. The company se